Clinical Characteristics of Intensive Care Unit Patients with Carbapenem Resistant Acinetobacter Baumannii Isolated from Sputum.
10.4046/trd.2006.60.2.228
- Author:
Sung Won LEE
1
;
Heui Sug JO
;
Woo Jin KIM
Author Information
1. Department of Internal Medicine, Kangwon National University Hospital, 17-1 Hyoja-3 Dong, Chunchon-Si, Kangwon-Do, Korea. pulmo2@knuh.or.kr
- Publication Type:Original Article
- Keywords:
Acinetobacter baumannii;
Drug resistance;
Carbapenem
- MeSH:
Acinetobacter baumannii*;
Acinetobacter*;
Anti-Bacterial Agents;
Anti-Infective Agents;
APACHE;
Bacteremia;
Comorbidity;
Cross Infection;
Drug Resistance;
Drug Resistance, Bacterial;
Humans;
Intensive Care Units*;
Critical Care*;
Medical Records;
Mortality;
Multivariate Analysis;
Pneumonia;
Respiration, Artificial;
Retrospective Studies;
Sputum*
- From:Tuberculosis and Respiratory Diseases
2006;60(2):228-234
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Acinetobacter baumannii is an important pathogen associated with nosocomial infections in intensive care units, and is responsible for nosocomial pneumonia, UTI, bacteremia, etc. The main concern is that this pathogen is often resistant to many antimicrobial agents, particularly to carbapenem. This study compared the clinical those of ICU admitted patients with the carbapenem resistant A. baumannii isolated from the sputum with characteristics of patients with carbapenem sensitive A. baumannii. METHODS: A total of 49 patients with A. baumannii from a sputum culture who were admitted to the ICU from January to December 2003 were enrolled in this study. This study evaluated the demographic variables, mortality, APACHE II score, comorbidity, antibiotics used, hospital and ICU stay, Clinical Pulmonary Infection Score, and mechanical ventilation. A retrospective analysis was made by a review of the patients' medical records. RESULTS: Carbapenem sensitive and resistant A. baumannii was isolated from 23 patients and 26 patients respectively. Univariate analysis revealed renal disease, the use of carbapenem and aminoglycoside to be statistically significant factors for carbapenem resistance. Multivariate analysis revealed carbapenem use(p=0.024; OR, 8.17; CI 1.32 to 50.68) to be positively associated with carbapenem resistance, and aminoglycoside use(p=0.026; OR, 0.18; CI, 0.04 to 0.82) to be negatively associated with carbapenem resistance. There was no significant difference in mortality between the carbapenem sensitive and resistant group(30 vs 42%. P=0.39). CONCLUSION: The occurrence of carbapenem resistant A. baumannii is positively associated with carbapenem use and negatively associated with aminoglycoside use. Carbapenem resistance in the sputum culture did not affect the mortality rate.
